“Making a Murderer” filmmakers Laura Ricciardi and Moira Demos are set adapt the serialized Huffington Post article “America’s Most Admired Lawbreaker” for TV. The project is the first under a new first-look deal between Sonar Entertainment and George Clooney and Grant Heslov’s Smokehouse Pictures.
Written by journalist Steven Brill, “America’s Most Admired Lawbreaker” tells the story of a a division of pharmaceutical giant Johnson & Johnson that created a powerful antipsychotic drug and marketed it aggressively to children and the elderly, while allegedly withholding data about its terrible side effects. Johnson & Johnson agreed to pay more than $2 billion in penalties and settlements, but sold a reported $30 billion worth of the drug worldwide.
Nicki Paluga will adapt the article to series with Ricciardi and Demos, with the latter two directing. The scripted event series does not yet have an episode count.
The project and the deal with Sonar are part of a continued effort by Smokehouse to push into television. The company is already developing “Ms,” a miniseries about Gloria Steinem and the founding of Ms Magazine, at HBO, and “The Studio,” about a movie studio in the 1990’s, Showtime.
“We couldn’t be more excited to be in business with George and Grant and their talented team at Smokehouse,” said Sonar CEO Thomas Lesinski. “Smokehouse has a stellar track record of delivering commercial and critically acclaimed content. Smokehouse will be a great partner for Sonar Entertainment, as the two companies align perfectly in our approaches to premium TV programming.”
Social Media, Risk, Cross-Functional and Strategy Renowned author and literary critic Lawrence Clark Powell said, “Write to be understood, speak to be heard, read to grow.” The idealism inherent in this statement is inspirational for the pharmaceutical industry when overcoming communication challenges. Barriers are eliminated through insightful interpretation of the written word, verbalization of …
Conrats PRESS RELEASE The corporate reputation of the pharmaceutical industry in 2015—the patient perspective (5th edition) Report published by PatientView London, March 10th, 2016. This report is based on the findings of a PatientView November 2015-January 2016 survey exploring the views of 1,075 patient groups from 72 countries, and focusing on differing medical specialties. The report…
Congrats to @Viiv @AbbVie @Lundbeck @janssen & @novonordisk Top 5 out of 48 say patient groups
In these exclusive videos eyeforpharma's Paul SImms spoke with Eduardo Sanchiz and Alfonso Ugarte, resp CEO and Senior Director of Global Business Units of Almirall, on the changing pharma landscape, patient value and rewriting the business plan.
Scores of leading biopharma C-suite and senior executives congregated at IDEA Pharma’s The Future of Pharma panel discussion event to hear the company announce who it believes are the top 10 most innovative and exciting companies selected from the whole of the industry, as it launches its new index - The IDEA Index.
But not all these companies have good reputations despite being good at innovation
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.